BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy

NCT03294304 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Muscle Invasive Bladder Cancer

Interventions

DRUG: Nivolumab
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]